147699-19-2

• 常用中文名：1-N-Boc-O-甲磺酰－羟乙基哌啶
• 常用英文名：1-BOC-4-(2-METHANESULFONYLOXY-ETHYL)-PIPERIDINE
• CAS号：147699-19-2
• 分子式：C₁₃H₂₅NO₅S
• 分子量：307.40600
• 发布时间：2018-12-28 16:14:02
• 更新时间：2024-01-09 20:13:26

名称

• 中文名: 1-N-Boc-O-甲磺酰－羟乙基哌啶
• 英文名: tert-butyl 4-(2-methylsulfonyloxyethyl)piperidine-1-carboxylate
• 中文别名: 1-N-Boc-O-甲磺酰-羟乙基哌啶
• 英文别名: 1-tert-butyloxycarbonyl-4-[2-(methanesulfonyloxy)ethyl]-piperidine; 1-(1-tert-Butyloxycarbonyl-piperidin-4-yl)-2-methanesulphonyloxyethane; t-butyl 4-(2-((methylsulfonyl)oxy)ethyl)-1-piperidinecarboxylate; 1-Boc-4-(2-(methylsulfonyloxy)ethyl)piperidine; tert-butyl 4-[2-(methanesulfonyloxy)ethyl]piperidine-1-carboxylate; N-t-butoxycarbonyl-4-piperidylethyl methanesulfonate; 1-N-BOC-4-(2-METHANESULFONYLOXYETHYL)PIPERIDINE; tert-butyl 4-(2-((methylsulfonyl)oxy)ethyl)piperidine-1-carboxylate; 2-(1-tert-Butoxycarbonylpiperid-4-yl)ethyl methanesulfonate

物化性质

• 分子式: C₁₃H₂₅NO₅S
• 分子量: 307.40600
• 精确质量: 307.14500
• PSA: 81.29000
• LogP: 3.01850
• 储存条件: 2-8°C

安全

• 海关编码: 2933399090

合成路线

124-63-0 89151-44-0 ~99% 147699-19-2

文献：MYRIAD GENETICS, INC. Patent: WO2009/65035 A1, 2009 ; Location in patent: Page/Page column 141-142 ;

108-20-3 124-63-0 89151-44-0 ~% 147699-19-2

文献：Karl Thomae GmbH Patent: US5681841 A1, 1997 ;

79099-07-3 ~% 147699-19-2

文献：GRUENENTHAL GmbH Patent: US2012/71461 A1, 2012 ;

135716-08-4 ~% 147699-19-2

文献：GRUENENTHAL GmbH Patent: US2012/71461 A1, 2012 ;

135716-09-5 ~% 147699-19-2

文献：GRUENENTHAL GmbH Patent: US2012/71461 A1, 2012 ;

24424-99-5 ~% 147699-19-2

文献：SYNTA PHARMACEUTICALS CORP.; CHIMMANAMADA, Dinesh, U.; YING, Weiwen Patent: WO2013/158644 A2, 2013 ;

622-26-4 ~% 147699-19-2

文献：SYNTA PHARMACEUTICALS CORP.; CHIMMANAMADA, Dinesh, U.; YING, Weiwen Patent: WO2013/158644 A2, 2013 ;

上下游产品

上游产品  8
124-63-0 89151-44-0 108-20-3 79099-07-3
135716-08-4 135716-09-5 24424-99-5 622-26-4
下游产品  2
146093-46-1 958025-66-6

海关

海关编码	2933399090
中文概述	2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期
Summary	2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%